Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for coronary slow flow
IRCT20220516054874N19Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Slow Coronary Flow (SCF) comparing Pentoxifylline plus usual care with Placebo plus usual care (2 arms). Primary endpoints: Left ventricular ejection fraction, Left atrial volume index and 2 more. Started Aug 2024; status: completed.
02
Drugs
pentoxifylline
03
Conditions
Slow Coronary Flow (SCF)
Beyond the preview
Go deeper on IRCT20220516054874N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220516054874N19.